CPOP has a multidisciplinary team of advisors from various departments at Stanford, Silicon Valley, and the broader community.
Mildred Cho, PhD
Dr. Mildred Cho is Professor (Research) of Pediatrics and of Medicine and Associate Director of the Stanford Center for Biomedical Ethics (SCBE). She has extensive experience developing research ethics training programs, including the basis for the current curriculum of the Responsible Conduct of Research course at SCBE. She has also prepared curricula tailored for specific areas of biomedical research, such as courses developed for genetic researchers as a co-investigator of an NIH-funded project, “Education in Genetics and Ethics” (EDGE). In addition, as Principal Investigator of an NIH Center for Excellence in Ethical, Legal and Social Implications Research, she established an interdisciplinary ethics training program that incorporates biomedical ethics, health law, social science research methods, and human genetics. Dr. Cho also developed case-based research ethics training materials from the Benchside Ethics Consultation Service she established at Stanford University in 2005 as part of the Center for Excellence. The service is now supported by Stanford University’s Clinical and Translational Science Award.
For more information, go to: https://med.stanford.edu/profiles/mildred-cho
Heidi Feldman, MD, PhD
Dr. Heidi Feldman is the Ballinger-Swindells Endowed Professor in Developmental and Behavioral Pediatrics and Professor of Pediatrics in Neonatal and Developmental Medicine at Stanford University School of Medicine. She was a member of the first sub-board for Developmental-Behavioral Pediatrics at the American Board of Pediatrics and President for the Society of Developmental-Behavioral Pediatrics. She currently serves as Medical Director for the Mary L. Johnson Developmental and Behavioral Pediatrics Program at Lucile Packard Children’s Hospital. Dr. Feldman’s research interests have focused on children with various clinical disorders, including those with intellectual disability, neurological injury, and children born preterm. Most recently, she has conducted studies that use neuroimaging techniques to understand the neural basis of adverse outcomes after preterm birth.
For more information, go to: https://med.stanford.edu/profiles/heidi-feldman
Jeremy Goldhaber-Fiebert, PhD
Dr. Jeremy Goldhaber-Fiebert is Assistant Professor of Medicine and of Health Research and Policy (by courtesy) at Stanford University School of Medicine. He is also a core faculty member of Stanford Center for Health Policy/Primary Care and Outcomes Research. His research focuses on using the tools of decision science, cost-effectiveness analysis, econometrics, and behavioral economics. Additionally, his research agenda centers on (1) using simulation modeling to connect the experiences and exposures of childhood to health outcomes over a lifetime and (2) incorporating behavioral responses into cost-effectiveness analyses. Currently, Dr. Goldhaber-Fiebert is conducting randomized controlled trials to examine the effects of behavioral economic nudges and commitment contracts in promoting long-term exercise habits.
For more information, go to: https://med.stanford.edu/profiles/jeremy-goldhaber-fiebert
Lanetta Jordan, MD, MPH, MSPH
Dr. Lanetta Jordan is President of the Foundation for Sickle Cell Disease Research, Chief of Quality and Clinical Operations for the Sickle Cell Care and Research Network (SCCRN), and Editor-in-Chief for the Journal of Sickle Cell Disease and Hemoglobinopathies. Previously, she established and directed the Department of Sickle Cell Services at Memorial Healthcare System, which was the first to receive “Disease-Specific Certification” from The Joint Commission. She helped develop the Sickle Cell Disease and Thalassemia National Registry and Health Record, served on the National Heart, Lung, and Blood Advisory Council of the National Institutes of Health, and was formerly the Chief Medical Officer for the Sickle Cell Disease Association of America. Dr. Jordan’s research on sickle cell disease has looked to eliminate health and health care disparities, improve care coordination, establish all-encompassing treatment, and set continuity of care guidelines.
For more information, go to: https://www.linkedin.com/pub/lanetta-jordan/10/884/737
Abby King, PhD
Dr. Abby King is Professor of Health Research & Policy and Medicine at Stanford and a senior faculty member at the Stanford Prevention Research Center (SPRC), which investigates ways to prevent disease and promote health through practical, science-based solutions. She is also Director of the Healthy Aging Research & Technology Solutions Laboratory at SPRC, which develops, tests, and disseminates information technologies that promote health and prevent disease. Dr. King has served as President of the Society of Behavioral Medicine, Member of the US Secretary of DHHS Scientific Advisory Committee for National Health Promotion and Disease Prevention, and Member of the Academy of Behavioral Science Research. Her research focuses on applying social cognitive theory and other behavioral approaches to achieve large-scale change in disease prevention and health promotion.
For more information, go to: https://med.stanford.edu/profiles/abby-king
Thomas Robinson, MD, MPH
Dr. Thomas Robinson is the Irving Schulman, MD Endowed Professor in Child Health and Professor of Pediatrics and of Medicine (Stanford Prevention Research Center) at Stanford University. He is also the Associate Director of the Center for Policy, Outcomes and Prevention. As Director of the Stanford Solutions Science Lab and the Center for Health Weight, he conducts solution-oriented research to develop and evaluate health promotion and disease prevention interventions. His work emphasizes the use of randomized controlled trials to test the efficacy and effectiveness of theory-driven behavioral, social, technological, environmental, and policy interventions on a variety of health risk factors and outcomes. Dr. Robinson’s research is grounded in social cognitive models of human behavior, uses rigorous methods, and is performed in generalizable settings with diverse populations, making the results of his research more relevant for clinical and public health practice and policy.
For more information, go to: https://med.stanford.edu/profiles/thomas-robinson
Hugh O’Brodovich, MD, FRCP(C)
Dr. Hugh O’Brodovich is the Arline and Pete Harman Professor and Chairman of Pediatrics at Stanford University School of Medicine, Physician in Chief of Lucile Packard Children’s Hospital, and Director of the Child Health Research Institute at Stanford. In addition, he serves as a Council member of the American Pediatric Society and a Selection Committee member of the Pediatric Scientist Development Program. His current research focuses on developing new therapies to prevent and treat the respiratory distress syndrome (RDS) and its sequelae, bronchopulmonary dysplasia (BPD).
For more information, go to: https://med.stanford.edu/profiles/hugh-obrodovich
Barry Zuckerman, MD
Dr. Barry Zuckerman is Professor and Chair Emeritus of the Department of Pediatrics at the Boston University School of Medicine and Professor of Public Health at the Boston University School of Public Health. During his 19-year tenure as Chairman of Pediatrics, he fostered innovative programs and initiatives to address the social determinants of health, particularly for children in urban settings. He is Co-founder of Reach Out and Read, a national non-profit organization that advocates for childhood literacy, and the Medical-Legal Partnership for Children, which provides lawyers to help patients navigate the complex legal systems that hold solutions to the many social determinants of health. He also helped start Health Leads at Boston Medical Center, which connects families to resources that impact their children’s health (e.g., food, health insurance, job training, housing, fuel assistance). In addition, Dr. Zuckerman has been active in advocating for people with sickle cell disease and has co-authored several publications to raise the issue of equity and quality in health service provision.
Mark Anderson, PhD
Dr. Mark Anderson is Principal at Applied Development Corporation and currently a member of the American Mathematics Society and American Institute of Certified Public Accountants. He has a robust background in mathematics, physics, software engineering, and finance. His knowledge of modern computing systems stems from extensive educational training and practical experience with current technologies for developing web services (e.g., web servers, server-side scripting, databases, client-side scripting, markup languages, data style formatting, communication protocols) and mobile applications. He has experience provisioning physical servers and virtual machines in cloud computing environments, as well as substantial knowledge of software management in the Linux operating system. In addition, Dr. Anderson is well-versed in the application of cryptographic techniques to secure PHI (e.g., symmetric encryption, public key encryption, key agreement, cryptographic hashing, secure communication protocols).
Kristen Chan (Design)
Kristen Chan is a Senior Designer (Data Visualization/User Experience) at LinkedIn. She loves data visualization and describes herself as a visual problem solver. Combining her Engineering training with Graphic Design, she researches, creates, and describes relationships through analyzing data, understanding visual perception, and aesthetic design.
For more information, go to: https://www.linkedin.com/in/kristenchan1
Steven Charlap, MD, MBA
Dr. Steven Charlap is Co-founder and CEO of HealthDrive, the largest U.S. provider of medical and dental services to extended care facilities, as well as Founder and Chief Medical Officer of MDPrevent, a multi-disciplinary, integrated primary care and preventive medicine practice focused on helping patients make lasting lifestyle changes to achieve exceptional lives. His keen interests include identifying well-done, actionable clinical studies focused on improving health and life-span. His life goal is to play a meaningful role in the advancement of scientific breakthroughs that can both improve human longevity and our quality of life.
For more information, go to: http://dci.stanford.edu/steven-s-charlap-md-mba/
Richard (Rick) A. Kimball, Jr. was an investment banker and venture capitalist for 26 years at Goldman Sachs, Morgan Stanley, and Millennium Technology Partners. He retired as a partner at Goldman Sachs in 2012 where he was Co-head of Global Healthcare Investment Banking and Co-head of Healthcare, Consumer and Retail Equity Capital Markets. Previously, Kimball worked at Morgan Stanley for 17 years where he ran Healthcare Equity Capital Markets and Healthcare Services Investment Banking. He was Co-founder and Managing Partner of Millennium Technology Partners, a venture capital firm focused on early-stage Internet infrastructure. As Chief Strategy and Growth Officer at Accretive Health, a healthcare technology company, he led the development of a transformation strategy to evolve the company’s innovative revenue cycle management business by facilitating deeper patient engagement by hospitals and building the foundation for population health programs.
For more information, go to: http://dci.stanford.edu/richard-a-kimball-jr/
Manuel Rivera is Co-founder of CareMessage, a health education and care coordination non-profit start-up, backed by Y Combinator, The Pershing Square Foundation, and winner of Google.org Global Impact Awards, which aims to increase patient health literacy and compliance via text, voice, and email messaging. As the Chief Product Officer and Chief Operating Officer, he is experienced in productizing input from providers and the patient experience design team, as well as facilitating communication with the legal team to ensure compliance with HIPAA regulations. He also created a Text-messaging Coaching Programs solution and localized text-messaging content for early pilots with a Spanish-speaking audience.
For more information, go to: https://www.linkedin.com/in/manuelriveravega